The Roboangio, designed and manufactured by Abrobo, is a new interventional robotic system intended for use in the remote delivery and manipulation of cerebral guidewires and catheters during cerebral angiography procedures. With the design of a master-slave control solution, it enables physicians to stay away from radiation environment while preserving complete control. The system has been well acknowledged by many clinical experts, thanks to its intuitive interaction and robotic precision.

Shenzhen Institute of Advanced Biomedical Robot Co.,Ltd., also known as Abrobo, was founded in June 2020. The company specializes in design, development and manufacturing of pan-vascular interventional robotic systems that promote the industrialization of interventional robotic technology. As a pioneer in the field of interventional robotic systems, Abrobo upholds user-centered product development principle. By January 2024, Abrobo has obtained more than 460 pieces of intellectual property involving both domestic and international invention patents.

Abrobo, also known as Shenzhen Institute of Advanced Biomedical Robot Co.,Ltd., founded in June 2020, is a high-tech enterprise focusing on design, development and manufacturing of the pan-vascular interventional surgical robotics. As a pioneer in the field, Abrobo values insights of clinical needs and provides designs with intuitive human-machine interaction, which has been well acknowledged by top-level clinical experts. By January 2024, Abrobo has obtained more than 460 pieces of intellectual property involving both domestic and international invention patents.